Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

As soluções de inteligência artificial médica da Ada obtêm registro como dispositivo médico Classe II no Brasil


News provided by

Ada Health

Dec 14, 2021, 06:00 ET

Share this article

Share toX

Share this article

Share toX

- A empresa global de saúde digital Ada Health continua fortalecendo sua posição como líder no fornecimento de inteligência artificial (IA) médica de confiança, obtendo o registro como um dispositivo médico no Brasil.

- A Ada é a primeira e única plataforma de avaliação de sintomas e navegação de cuidados baseada em IA totalmente licenciada para operar no mercado brasileiro, tendo obtido o status de dispositivo médico Classe II pela agência reguladora nacional de vigilância sanitária, a ANVISA.

- Espera-se que o anúncio de hoje reforce ainda mais o interesse de clientes nos benefícios das soluções de IA médica da Ada.

BERLIM, NOVA YORK e BRASÍLIA, Brasil, 14 de dezembro de 2021 /PRNewswire/ -- A Ada Health, empresa global de saúde digital, anunciou hoje que sua plataforma de avaliação de sintomas e navegação de cuidados baseada em inteligência artificial (IA) obteve o status de dispositivo médico Classe II no Brasil. A Ada é a primeira e única plataforma digital de avaliação de saúde baseada em IA a conseguir isso no Brasil, demonstrando o contínuo compromisso da empresa com a excelência médica e regulatória.

Com mais de 200 milhões de habitantes, o Brasil é um dos maiores mercados de saúde do mundo. A ANVISA (Agência Nacional de Vigilância Sanitária), agência reguladora de vigilância sanitária brasileira, estabelece padrões rigorosos para empresas que buscam o status de dispositivo médico Classe II e exige que os fornecedores apresentem evidências clínicas e sigam processos transparentes de gerenciamento de qualidade. A Ada se orgulha da avaliação rigorosa de suas soluções de IA médica, garantindo que ela atenda aos mais ambiciosos padrões da indústria em vários mercados globais. O cumprimento das exigências da ANVISA é mais uma prova do compromisso da Ada em fornecer aos clientes e usuários soluções de saúde de alta qualidade em escala global. 

As soluções empresariais da Ada voltadas para a IA são utilizadas por uma ampla gama de sistemas de saúde, operadoras de saúde, empresas farmacêuticas e organizações multinacionais sem fins lucrativos em todo o mundo. Ao integrar as soluções da Ada em suas jornadas digitais de saúde, estas organizações têm como objetivo melhorar a qualidade e a eficácia do atendimento aos seus pacientes e agilizar os processos para os profissionais de saúde. Seu sucesso contínuo permitiu à Ada crescer rapidamente e assegurar parcerias com organizações líderes em diversas geografias, incluindo os EUA, França, Portugal, Egito e Arábia Saudita. O status de dispositivo médico Classe II da Ada fornece garantias adicionais para as organizações de saúde no Brasil que aplicam padrões rigorosos às suas próprias soluções e às soluções de seus fornecedores e valorizam a excelência clínica comprovada. Espera-se que o anúncio de hoje apoie e acelere a expansão da Ada na região da América do Sul com o potencial de melhorar os resultados e experiências de saúde para milhões de pessoas.

O co-fundador e CEO da Ada, Daniel Nathrath, disse:

"Nosso objetivo é melhorar as jornadas de saúde para 1 bilhão de pessoas em todo o mundo. Para atingir este objetivo, sabemos que precisamos demonstrar que nossas soluções podem proporcionar os mais altos níveis de qualidade médica, segurança e precisão. É por isso que estamos empenhados em atender aos mais ambiciosos requisitos regulatórios e até mesmo superar as expectativas de nossos clientes em cada um dos maiores mercados de saúde do mundo. Estamos incrivelmente orgulhosos de ser a primeira plataforma de avaliação de saúde digital orientada por inteligência artificial a ter cumprido os requisitos da ANVISA para a certificação de dispositivos médicos Classe II e esperamos acelerar nosso crescimento no país nos próximos meses".

Sobre a Ada

A Ada é uma empresa global de saúde fundada por médicos, cientistas e pioneiros da indústria para criar novas possibilidades de saúde pessoal e transformar o conhecimento em melhores resultados. Seu sistema central conecta o conhecimento médico com tecnologia inteligente para ajudar todas as pessoas a gerenciar ativamente suas organizações de saúde e de saúde para oferecer um atendimento eficaz. A empresa trabalha com os principais sistemas de saúde, prestadores de saúde, organizações de saúde e governos para realizar esta visão. A plataforma Ada tem 11 milhões de usuários em todo o mundo, e completou 25 milhões de avaliações desde seu lançamento global em 2016. A sofisticada tecnologia de IA da Ada está atualmente disponível em 11 idiomas, incluindo o português.

Para saber mais, visite https://ada.com.

FONTE Ada Health

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Ada Health Clinical AI Turns Symptom Uncertainty Into Appropriate Action, Finds NEJM AI Study Conducted with CUF in Portugal

Ada Health Clinical AI Turns Symptom Uncertainty Into Appropriate Action, Finds NEJM AI Study Conducted with CUF in Portugal

Ada Health, a leading clinical AI company that helps people understand their symptoms and navigate care safely and efficiently, today announced the...

Ada Health Patents the Clinical Layer That Makes LLMs Safe for Healthcare

Ada Health Patents the Clinical Layer That Makes LLMs Safe for Healthcare

Ada Health, a leading clinical AI company that helps people understand their symptoms and navigate care safely and efficiently, today announced that...

More Releases From This Source

Explore

Artificial Intelligence

Artificial Intelligence

The Latest Artificial Intelligence News

The Latest Artificial Intelligence News

Health Care & Hospitals

Health Care & Hospitals

Medical Equipment

Medical Equipment

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.